Abeona Therapeutics Inc. (0H7R.L)
USD 5.88
(-2.0%)
USD 5.88
(-2.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Assets | 64 Million | 64.21 Million | 79.58 Million | 151.19 Million | 223.38 Million | 174.39 Million |
| Total Current Assets | 55.73 Million | 53.09 Million | 55.4 Million | 97.74 Million | 132.38 Million | 88.85 Million |
| Cash And Short Term Investments | 52.22 Million | 52.48 Million | 50.01 Million | 95.03 Million | 129.25 Million | 84.96 Million |
| Cash and Cash Equivalents | 14.47 Million | 14.55 Million | 37.92 Million | 12.59 Million | 129.25 Million | 18.75 Million |
| Short Term Investments | 37.75 Million | 37.93 Million | 12.08 Million | 82.43 Million | - | 66.21 Million |
| Net Receivables | 2.44 Million | 188 Thousand | 3 Million | - | - | 81 Thousand |
| Inventory | -2.44 Million | - | 1.00 | - | - | 1.00 |
| Other Current Assets | 3.51 Million | 424 Thousand | 2.38 Million | 2.7 Million | 3.13 Million | 3.8 Million |
| Total Non-Current Assets | 8.26 Million | 11.11 Million | 24.18 Million | 53.45 Million | 90.99 Million | 85.54 Million |
| Net PPE | 7.98 Million | 11.07 Million | 21.74 Million | 18.35 Million | 21.2 Million | 9.44 Million |
| Good Will And Intangible Assets | - | - | 1.38 Million | 33.96 Million | 68.64 Million | 75.5 Million |
| Good Will | - | - | - | 32.46 Million | 32.46 Million | 32.46 Million |
| Intangible Assets | - | - | 1.38 Million | 1.5 Million | 36.17 Million | 43.04 Million |
| Long-Term Investments | - | - | 900 Thousand | 975 Thousand | 1.11 Million | 560 Thousand |
| Tax Assets | - | - | -1.00 | -32.46 Million | -32.46 Million | - |
| Other Non Current Assets | 276.99 Thousand | 43 Thousand | 159 Thousand | 32.62 Million | 32.5 Million | 37 Thousand |
| Other Assets | - | - | 1.00 | - | 1.00 | - |
| Total Liabilities | 49.17 Million | 37.45 Million | 28.21 Million | 48.64 Million | 44.95 Million | 40.35 Million |
| Total Current Liabilities | 13.42 Million | 7.77 Million | 16.62 Million | 41.95 Million | 38.7 Million | 20.35 Million |
| Account Payables | 1.85 Million | 1.81 Million | 4.32 Million | 4.69 Million | 3.76 Million | 6.12 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 998 Thousand | 1.77 Million | 1.81 Million | 2.04 Million | 1.69 Million | - |
| Deferred Revenue | -998 Thousand | - | 296 Thousand | 296 Thousand | 296 Thousand | 296 Thousand |
| Other Current Liabilities | 11.56 Million | 4.19 Million | 10.18 Million | 34.92 Million | 32.94 Million | 13.93 Million |
| Total Non Current Liabilities | 35.75 Million | 29.67 Million | 11.58 Million | 6.68 Million | 6.25 Million | 20 Million |
| Long-Term Debt | 4.4 Million | 5.85 Million | 7.56 Million | 1.42 Million | 6.25 Million | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 31.35 Million | 23.82 Million | 4.02 Million | -1.42 Million | -1.00 | 20 Million |
| Other Liabilities | - | - | 1.00 | 1.00 | 1.00 | - |
| Total Equity | 14.82 Million | 26.76 Million | 51.37 Million | 102.55 Million | 178.43 Million | 134.04 Million |
| Stock Holders Equity | 14.82 Million | 26.76 Million | 51.37 Million | 102.55 Million | 178.43 Million | 134.04 Million |
| Common Stock | 265 Thousand | 177 Thousand | 1.47 Million | 961 Thousand | 836 Thousand | 479 Thousand |
| Retained Earnings | -749.52 Million | -695.33 Million | -655.64 Million | -570.7 Million | -486.47 Million | -410.18 Million |
| Accumulated other comprehensive income | -66 Thousand | -129 Thousand | -27 Thousand | -10 Thousand | - | - |
| Common Stock Equity | 14.82 Million | 26.76 Million | 51.37 Million | 102.55 Million | 178.43 Million | 134.04 Million |
| Capital Lease Obligation | 5.4 Million | 5.85 Million | 7.56 Million | 5.26 Million | 6.25 Million | - |
| Total Investments | 37.75 Million | 37.93 Million | 12.98 Million | 83.41 Million | 1.11 Million | 66.77 Million |
| Total Debt | 4.4 Million | 7.62 Million | 9.37 Million | 8.73 Million | 7.95 Million | - |
| Net Debt | -10.07 Million | -6.92 Million | -28.55 Million | -3.86 Million | -121.3 Million | -18.75 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 134 Million | 74.82 Million | 64 Million | 64 Million | 66.08 Million | 53.55 Million |
| Total Current Assets | 125.9 Million | 66.72 Million | 55.73 Million | 55.73 Million | 57.26 Million | 44.03 Million |
| Cash And Short Term Investments | 123.04 Million | 62.68 Million | 52.56 Million | 52.56 Million | 54.09 Million | 37.11 Million |
| Cash and Cash Equivalents | 34.76 Million | 17.89 Million | 14.81 Million | 14.81 Million | 5.05 Million | 6.56 Million |
| Short Term Investments | 88.28 Million | 44.78 Million | 37.75 Million | 37.75 Million | 49.04 Million | 30.54 Million |
| Net Receivables | 1.64 Million | 2.23 Million | 2.44 Million | 2.44 Million | 2.2 Million | 5.72 Million |
| Inventory | - | - | - | - | - | 1.00 |
| Other Current Assets | 1.21 Million | 1.81 Million | 729 Thousand | 729 Thousand | 963 Thousand | 1.2 Million |
| Total Non-Current Assets | 8.09 Million | 8.1 Million | 8.26 Million | 8.26 Million | 8.82 Million | 9.51 Million |
| Net PPE | 7.99 Million | 7.98 Million | 7.98 Million | 7.98 Million | 8.68 Million | 9.4 Million |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | 99.99 Thousand | 114 Thousand | 276.99 Thousand | 276.99 Thousand | 139 Thousand | 108 Thousand |
| Other Assets | - | 1.00 | - | - | - | - |
| Total Liabilities | 60.76 Million | 83.7 Million | 49.17 Million | 49.17 Million | 44.04 Million | 44.2 Million |
| Total Current Liabilities | 16.84 Million | 11.88 Million | 13.42 Million | 13.42 Million | 8.41 Million | 9.44 Million |
| Account Payables | 3.09 Million | 3.36 Million | 1.85 Million | 1.85 Million | 2.59 Million | 3.47 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 4.01 Million | 1.04 Million | 998 Thousand | 998 Thousand | 1.64 Million | 1.59 Million |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 9.73 Million | 7.48 Million | 10.56 Million | 10.56 Million | 4.17 Million | 4.36 Million |
| Total Non Current Liabilities | 43.91 Million | 71.82 Million | 35.75 Million | 35.75 Million | 35.63 Million | 34.76 Million |
| Long-Term Debt | 16.13 Million | 18.07 Million | 4.4 Million | 4.4 Million | 4.04 Million | 4.37 Million |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 27.78 Million | 53.74 Million | 31.35 Million | 31.35 Million | 31.59 Million | 30.38 Million |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | 73.24 Million | -8.88 Million | 14.82 Million | 14.82 Million | 22.03 Million | 9.34 Million |
| Stock Holders Equity | 73.24 Million | -8.88 Million | 14.82 Million | 14.82 Million | 22.03 Million | 9.34 Million |
| Common Stock | 417 Thousand | 276 Thousand | 265 Thousand | 265 Thousand | 247 Thousand | 215 Thousand |
| Retained Earnings | -773.69 Million | -781.1 Million | -749.52 Million | -749.52 Million | -732.93 Million | -721.09 Million |
| Accumulated other comprehensive income | -134 Thousand | -184 Thousand | -66 Thousand | -66 Thousand | -99 Thousand | -95 Thousand |
| Common Stock Equity | 73.24 Million | -8.88 Million | 14.82 Million | 14.82 Million | 22.03 Million | 9.34 Million |
| Capital Lease Obligation | 3.01 Million | 4.04 Million | 4.4 Million | 4.4 Million | 4.04 Million | 4.37 Million |
| Total Investments | 88.28 Million | 44.78 Million | 37.75 Million | 37.75 Million | 49.04 Million | 30.54 Million |
| Total Debt | 23.16 Million | 23.16 Million | 5.4 Million | 5.4 Million | 5.69 Million | 5.97 Million |
| Net Debt | -11.59 Million | 5.27 Million | -9.41 Million | -9.41 Million | 642 Thousand | -589 Thousand |
SIYSIL
MEDANTA
BIR
TEXRAIL
OGEN
PSHZF